MedTrace Logo

Evaluating the Efficacy of Pediatric Lipid Screening Alerts

NCT04118348 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 13340

Last updated 2023-11-07

Study results available
· View outcomes & findings →

Summary

The purpose of the study is to evaluate prospectively the impact of different system alerts on the prescription of lipid panels to pediatric Geisinger patients (9-11 years old), as per the now-universal guidelines. This will help quantify the relative effectiveness of different alerts and combinations of alerts on provider prescribing behavior and patient uptake of screening.

Conditions

  • Hypercholesterolemia
  • Hypercholesterolemia, Familial
  • Hypercholesteremia in Children
  • Hyperlipidemia in Children

Interventions

BEHAVIORAL

Best Practice Alert

An Epic screen pops up for a provider during an eligible 9-11 year-old patient's visit. A prompt requires that the provider respond, either confirming the prescription of a lipid panel or opting out with an acknowledgment/reason for declining the test.

BEHAVIORAL

Health Maintenance Topic

An Epic health maintenance topic appears for a provider during an eligible 9-11 year-old patient's visit. The HMT will be highlighted for enhanced visibility, until or unless action is taken.

Sponsors & Collaborators

  • Geisinger Clinic

    lead OTHER

Principal Investigators

  • Amir Goren, PhD · Geisinger Clinic

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
DOUBLE
Model
FACTORIAL

Eligibility

Min Age
9 Years
Max Age
11 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-10
Primary Completion
2020-10-11
Completion
2020-10-11

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04118348 on ClinicalTrials.gov